Therapeutic compositions and methods for use of heparin-binding

Details Therapeutic compositions and methods for use of heparin-binding Therapeutic compositions and methods for use of heparin-binding

1995-05-26

1997-06-24

Allen, Marianne P.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

A61K 3818

Patent

active

056417438

ABSTRACT:
A group of growth factors, designated heparin-binding brain mitogens (HBBMs), is disclosed. The HBBMs are isolated from brain tissue by a sequence of purification steps. The growth factors may be useful in the promotion of angiogenesis, such as in the promotion of wound healing, bone healing and in the treatment of burns, as well as in promoting the formation, maintenance and repair of tissue, in particular, neural tissue.

REFERENCES:
patent: 4997929 (1991-03-01), Collins et al.
patent: 5171842 (1992-12-01), Bohlen et al.
Merenmier et al. 1990. J. Biol. Chem., 265(28):16721-16724.
Teyuka et al. 1990. Biochem. Biophys. Res. Comm. 173(1): 246-251.
Bohlen et al. 1984. Proc. Natl. Acad. Sci. 81: 5364-5368.
Smith et al. 1984. Biochem. Biophys. Res. Comm. 119(1): 311-318.
Kato. Y. 1987. Adv. Chromatogr. 26: 97-115.
Milner et al. 1989. Biochem. Biophys. Res. Comm. 165(3): 1096-1103.
Gospodarowicz, J. Biol. Chem., 250, 2515-2520 (1975).
Gospodarowicz et al., J. Biol. Chem., 253, 3736-3743 (1978).
Bohlen et al., Anal Biochem., 126, 144-152 (1982).
Thomas et al., Proc. Nat. Acad., Sci., 81, 357-361 (1984).
Gospodarowicz et al., Proc. Nat. Acad. Sci., 81, 6963-6967 (1984).
Bophlen et al., EMBO J., 4, 1951-1956 (1985).
Esch et al., Proc. Nat. Acad. Sci., 82, 6507-6511 (1985).
Gimenez-Gallego et al., Science, 230, 1385-1388 (1985).
Bohlen et al., FEBS Lett. 185, 177-181 (1985).
Gautschi-Sova et al., BBRC, 140, 874-880 (1986).
Lobb et al., Anal. Biochem., 154, 1-14 (1986).
Lobb et al., J. Biol. Chem., 261, 1924-1928 (1986).
Gautschi-Sova et al., Biochemistry, 26, 5844-5847 (1987).
Kuo et al. 1990 J. Biol. Chem., 265(31): 18749-18752.
Bohlen P. et al., J. Cell. Biochem. Suppl. 12A, p. 221, abstract D401.
Kuber et al., 1990 Neurochemical Research, 15(4): 435-439.
Rauvala et al., 1987 J. Biol. Chem. 262(34): 16625-16635.
Li et al. 1990 Science 250: 1690-1694.
Fischer et al. 1987. Nature 329: 65-68.
Miller et al. 1989. Biochem. Biophys. Res. Comm. 165(3): 1096-1103.
Kovesdi et al. 1990. Chem. Biophys. Res. Comm. 172(2): 850-854.
Hennessy et al., 1989, J. Cell Biol. 108: 729-736.
Risau et al. 1988. Embo J. 7(4): 959-962.
Crabb et al., 1986. Biochem. Biophys. Res. Commun. 136(3): 1155-1161.
Lobb et al., 1985. Biochem. Biophys. Res. Commun. 131(2): 586-592.
Jaye et al. 1987. J. Biol. Chem. 262(34): 16612-16617.
Rauvala, H. 1989. EMBO J. 8(10): 2933-2942, (abstract).

Affiliated with

Also associated with

Rating

Therapeutic compositions and methods for use of heparin-binding does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic compositions and methods for use of heparin-binding , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compositions and methods for use of heparin-binding will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-149109